Therefore, a vaccine delivery format supporting efficient induction of CD4+ and CD8+ specific T cells on the fundament of strong expression and efficient antigen processing and presentation is expected to support elimination of premalignant PV transduced cells - provided that early neoplasias display sufficient amounts of E1/MHC-I complexes on their cell surface. Here, CD8A is linked to neoplasm.